| pubmed-article:10421260 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0019158 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0861876 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0205462 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C1522484 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0032790 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0036525 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0679199 | lld:lifeskim |
| pubmed-article:10421260 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
| pubmed-article:10421260 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:10421260 | pubmed:dateCreated | 1999-8-17 | lld:pubmed |
| pubmed-article:10421260 | pubmed:abstractText | The hepatitis activity index (HAI) score describes the histologic status of accompanying chronic hepatitis and was established by pathologists. The aim of this study was twofold: 1) to investigate the correlation between intrahepatic metastatic recurrence (IM) and the HAI score of the noncancerous region of the liver and 2) to estimate the usefulness of postoperative preventive chemotherapy in patients with hepatocellular carcinoma (HCC). | lld:pubmed |
| pubmed-article:10421260 | pubmed:language | eng | lld:pubmed |
| pubmed-article:10421260 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10421260 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:10421260 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:10421260 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:10421260 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:10421260 | pubmed:issn | 0008-543X | lld:pubmed |
| pubmed-article:10421260 | pubmed:author | pubmed-author:YoshidaAA | lld:pubmed |
| pubmed-article:10421260 | pubmed:author | pubmed-author:TakaiYY | lld:pubmed |
| pubmed-article:10421260 | pubmed:author | pubmed-author:UenoSS | lld:pubmed |
| pubmed-article:10421260 | pubmed:author | pubmed-author:TanabeGG | lld:pubmed |
| pubmed-article:10421260 | pubmed:author | pubmed-author:AikouTT | lld:pubmed |
| pubmed-article:10421260 | pubmed:author | pubmed-author:YoshidomeSS | lld:pubmed |
| pubmed-article:10421260 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:10421260 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:10421260 | pubmed:volume | 86 | lld:pubmed |
| pubmed-article:10421260 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:10421260 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:10421260 | pubmed:pagination | 248-54 | lld:pubmed |
| pubmed-article:10421260 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:meshHeading | pubmed-meshheading:10421260... | lld:pubmed |
| pubmed-article:10421260 | pubmed:year | 1999 | lld:pubmed |
| pubmed-article:10421260 | pubmed:articleTitle | Postoperative prediction of and strategy for metastatic recurrent hepatocellular carcinoma according to histologic activity of hepatitis. | lld:pubmed |
| pubmed-article:10421260 | pubmed:affiliation | First Department of Surgery, Kagoshima University School of Medicine, Sakuragaoka, Japan. | lld:pubmed |
| pubmed-article:10421260 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:10421260 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:10421260 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10421260 | lld:pubmed |
